By Professor Wayne Denis Hall

Journal articles

Hall WD, 2005, 'Will nicotine genetics and a nicotine vaccine prevent cigarette smoking and smoking-related diseases?', Plos Medicine, 2, pp. 0860 - 0863, http://dx.doi.org/10.1371/journal.pmed.0020266

Hall W, 2005, 'British drinking: A suitable case for treatment?', BMJ, 331, pp. 527, http://dx.doi.org/10.1136/bmj.331.7516.527

Hall W; Kimber J, 2005, 'Being realistic about benefits of supervised injecting facilities', Lancet, 366, pp. 271 - 272, http://dx.doi.org/10.1016/S0140-6736(05)66476-8

Edwards G; West R; Babor TF; Hall W; Marsden J, 2005, 'The integrity of the science base: A test case', Addiction, 100, pp. 581 - 584, http://dx.doi.org/10.1111/j.1360-0443.2005.01109.x

Lucke JC; Hall W, 2005, 'Who wants to live forever?', EMBO Reports, 6, pp. 98 - 102, http://dx.doi.org/10.1038/sj.embor.7400339

Hall W; Christie M; Currow D, 2005, 'Cannabinoids and cancer: Causation, remediation, and palliation', Lancet Oncology, 6, pp. 35 - 42, http://dx.doi.org/10.1016/s1470-2045(04)01711-5

Hall WD; Lynskey M, 2005, 'Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs', Drug and Alcohol Review, 24, pp. 39 - 48, http://dx.doi.org/10.1080/09595230500126698

Hall WD, 2005, 'The prospects for tobacco harm reduction', International Journal of Drug Policy, 16, pp. 139 - 142, http://dx.doi.org/10.1016/j.drugpo.2005.04.002

Degenhardt LJ; Day CA; Conroy EJ; Gilmour S; Hall WD, 2005, 'Age differentials in the impacts of reduced heroin: Effects of a `heroin shortage` in NSW, Australia', Drug and Alcohol Dependence, 79, pp. 397 - 404, http://www.sciencedirect.com/science/article/B6T63-4G94HV1-1/2/12ce425f6d4829bab75c04f227f1669f

Hall WD; Ward RL; Liauw WS; Brien JE; Lu CY, 2005, 'Tailoring access to high cost, genetically targeted drugs', Medical Journal of Australia, 182, pp. 607 - 608

Day CA; Degenhardt LJ; Gilmour S; Hall WD, 2005, 'The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia', BMC Public Health, 5

Hall W, 2004, 'Feeling 'better than well'', EMBO Reports, 5, pp. 1105 - 1109, http://dx.doi.org/10.1038/sj.embor.7400303

Hall W, 2004, 'New treatments for addiction: Behavioural, ethical, legal and social questions', ADDICTION, 99, pp. 1481 - 1481, http://dx.doi.org/10.1111/j.1360-0443.2004.00924.x

Edwards G; West R; Babor TF; Hall W; Marsden J, 2004, 'An invitation to an alcohol industry lobby to help decide public funding of alcohol research and professional training: A decision that should be reversed', Addiction, 99, pp. 1235 - 1236, http://dx.doi.org/10.1111/j.1360-0443.2004.00873.x

Hall W, 2004, 'Footnotes to hall (2004) - Reply to Wodak', ADDICTION, 99, pp. 1064 - 1064, http://dx.doi.org/10.1111/j.1360-0443.2004.00825.x

Wodak A; Hall W, 2004, 'Footnotes to Hall (2004) [2] (multiple letters)', Addiction, 99, pp. 1063 - 1064, http://dx.doi.org/10.1111/j.1360-0443.2004.00817.x

Hall W, 2004, 'The contribution of research to Australian policy responses to heroin dependence 1990-2001: A personal retrospection', Addiction, 99, pp. 560 - 569, http://dx.doi.org/10.1111/j.1360-0443.2004.00717.x

Hall W, 2004, 'Retrospections of a recovering drug researcher', Addiction, 99, pp. 153 - 154, http://dx.doi.org/10.1111/j.1360-0443.2003.00613.x

Rodgers A; Ezzati M; Vander Hoorn S; Lopez AD; Lin RB; Murray CJL; Fishman S; Caulfield LE; de Onis M; Blössner M; Hyder AA; Mullany L; Black RE; Stoltzfus RJ; Rice AJ; West KP; Lawes C; Law M; Elliott P; MacMahon S; James WPT; Jackson-Leach R; Ni Mhurchu C; Kalamara E; Shayeghi M; Rigby NJ; Nishida C; Lock K; Pomerleau J; Causer L; McKee M; Bull FC; Dixon T; Ham S; Neiman A; Pratt M; Rehm J; Room R; Monteiro M; Gmel G; Graham K; Rehn N; Sempos CT; Frick U; Jernigan D; Degenhardt L; Hall W; Warner-Smith M; Lynskey M; Slaymaker E; Walker N; Armstrong T; Collumbien M; Gerressu M; Cleland J; Prüss-Ustun A; Kay D; Fewtrell L; Bartram J; Cohen A; Anderson R; Ostro B; Dev Pandey K; Krzyzanowski M; Künzli N; Gutschmidt K; Pope A; Romieu I; Samet J; Smith K; Smith KR; Mehta S; Feuz M; Landrigan P; Ayuso JL; McMichael A; Campbell-Lendrum D; Kovats S; Edwards S; Wilkinson P; Tanser F; Le Sueur D; Schlesinger M; Andronova N; Nicholls R; Wilson T; Hales S; Concha M; Imel Nelson D; Fingerhut M; Leigh J; Corvalan C; Driscoll T; Kyle Steenland N; Punnett L; Tak SW; Phillips S; Hauri AM; Armstrong GL; Hutin YJF; Andrews G; Slade T; Corry J, 2004, 'Distribution of major health risks: Findings from the global burden of disease study', Plos Medicine, 1, pp. 044 - 055, http://dx.doi.org/10.1371/journal.pmed.0010027

Morley KI; Hall WD; Carter L, 2004, 'Genetic screening for susceptibility to depression: Can we and should we?', Australian and New Zealand Journal of Psychiatry, 38, pp. 73 - 80, http://dx.doi.org/10.1111/j.1440-1614.2004.01300.x

Yeh M; Morley KI; Hall WD, 2004, 'The policy and ethical implications of genetic research on attention deficit hyperactivity disorder', Australian and New Zealand Journal of Psychiatry, 38, pp. 10 - 19, http://dx.doi.org/10.1111/j.1440-1614.2004.01292.x

Hall WD; Morley KI; Lucke JC, 2004, 'The prediction of disease risk in genomic medicine.', EMBO Reports, 5 Spec No, pp. S22 - S26, http://dx.doi.org/10.1038/sj.embor.7400224

Hall W; Fergusson DM; Atakan Z; Smit F, 2004, 'The psychotogenic effects of cannabis use: Challenges in reducing residual uncertainties and communicating the risks [2] (multiple letters)', Addiction, 99, pp. 511 - 512, http://dx.doi.org/10.1111/j.1360-0443.2004.00698.x

Morley KI; Hall WD, 2004, 'Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: Some ethical and economic considerations', Journal of Molecular Medicine, 82, pp. 21 - 30, http://dx.doi.org/10.1007/s00109-003-0496-x

Hall WD; Degenhardt LJ; Teesson M, 2004, 'Cannabis use and psychotic disorders: an update', Drug and Alcohol Review, 23, pp. 433 - 443

Sachdev PS, 2004, 'Foreword', Sensorium - A neuroscience journal for Australasian clinicians, Issue 5, pp. 1 - 1

Yeh M; Morley KI; Hall WD, 2004, 'The Policy and Ethical Implications of Genetic Research on Attention Deficit Hyperactivity Disorder', Australian & New Zealand Journal of Psychiatry, 38, pp. 10 - 19, http://dx.doi.org/10.1177/0004867404038001-209

Hall W; Carter L; Morley K, 2003, 'Heroin addiction and the capacity for consent: A reply to Charland [3]', Addiction, 98, pp. 1775 - 1776, http://dx.doi.org/10.1111/j.1360-0443.2003.00568.x

Hall WD; Clark LT; Wenger NK; Wright JT; Kumanyika SK; Watson K; Horton EW; Flack JM; Ferdinand KC; Gavin JR; Reed JW; Saunders E; O'Neal W, 2003, 'For the patient. What is the Metabolic Syndrome and why is it important?', Ethnicity Disease, 13, pp. 546

Hall WD; Clark LT; Wenger NK; Wright JT; Kumanyika SK; Watson K; Horton EW; Flack JM; Ferdinand KC; Gavin JR; Reed JW; Saunders E; O'Neal W, 2003, 'The metabolic syndrome in African Americans: A review', Ethnicity and Disease, 13, pp. 414 - 427

Moncrieff J; Draper BM; Verberne TJ; Ankarberg PH; Hall WD; Mant A; Mitchell PB, 2003, 'Antidepressant prescribing and suicide [2] (multiple letters)', British Medical Journal, 327, pp. 288 - 289

Hall WD; Mant A; Mitchell PB, 2003, 'Antidepressant prescribing and suicide: Authors' reply', BMJ, 327, pp. 289, http://dx.doi.org/10.1136/bmj.327.7409.289

Hall W; Carter L; Morley KI, 2003, 'Addiction, ethics and scientific freedom', Addiction, 98, pp. 873 - 874, http://dx.doi.org/10.1046/j.1360-0443.2003.00457.x

Hall W; Carter L; Morley KI, 2003, 'Addiction, neuroscience and ethics', Addiction, 98, pp. 867 - 870, http://dx.doi.org/10.1046/j.1360-0443.2003.00400.x

Lynskey MT; Day C; Hall W, 2003, 'Alcohol and other drug use disorders among older-aged people', Drug and Alcohol Review, 22, pp. 125 - 133

Hall W, 2003, 'Heroin Century; Heroin Addiction Care and Control: The British System 1916-1984', BMJ, 326, pp. 400, http://dx.doi.org/10.1136/bmj.326.7385.400

Taylor DR; Hall W, 2003, 'Respiratory health effects of cannabis: position statement of the Thoracic Society of Australia and New Zealand.', Internal Medicine Journal, 33, pp. 310 - 313, http://dx.doi.org/10.1046/j.1445-5994.2003.00401.x

Hall W, 2003, 'The Australian policy debate about human embryonic stem cell research.', Health Law Review, 12, pp. 27 - 33

Dolan K; Shearer J; MacDonald MA; Mattick RP; Hall WD; Wodak AD, 2003, 'A randomized controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system', Drug and Alcohol Dependence, 72, pp. 59 - 65

Day CA; Topp LJ; Rouen DA; Darke S; Hall WD; Dolan K, 2003, 'Decreased heroin availability in Sydney in early 2001', Addiction, 98, pp. 93 - 95

Degenhardt LJ; Hall WD; Lynskey MT, 2003, 'Exploring the association between cannabis use and depression', Addiction, 98, pp. 1493 - 1504

Darke S; Hall WD, 2003, 'Heroin Overdose: Research and Evidence-Based Intervention', Journal of Urban Health - Bulletin of the New York Academy of Medicine, 80, pp. 189 - 200

Hall WD; Degenhardt LJ, 2003, 'Medical Marijuana Initiatives: Are they justified? How successful are they likely to be?', CNS Drugs, 17, pp. 689 - 697

Degenhardt LJ; Hall WD, 2003, 'Patterns of co-morbidity between alcohol use and other substance use in the Australian population', Drug and Alcohol Review, 22, pp. 7 - 13

Degenhardt LJ; Hall WD; Lynskey MT, 2003, 'Testing hypotheses about the relationship between cannabis use and psychosis', Drug and Alcohol Dependence, 71, pp. 37 - 48

Fry CL; Hall W, 2002, 'An ethical framework for drug epidemiology: Identifying the issues', Bulletin on Narcotics, 54, pp. 131 - 142

Hall W, 2002, 'Educating government officials about the health risks of cannabis', JOURNAL OF POLICY ANALYSIS AND MANAGEMENT, 21, pp. 121 - 125, http://dx.doi.org/10.1002/pam.1046

Hall W, 2002, 'Clearing the smoke: Assessing the science base for tobacco harm reduction', ADDICTION, 97, pp. 1480 - 1481, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179102000017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hall W, 2002, 'Stages and pathways of drug involvement: Examining the gateway hypothesis', ADDICTION, 97, pp. 1482 - 1482, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179102000019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hall W, 2002, 'The prospects for immunotherapy in smoking cessation', Lancet, 360, pp. 1089 - 1091, http://dx.doi.org/10.1016/S0140-6736(02)11134-2

Back to profile page